PMID- 36474304
OWN - NLM
STAT- MEDLINE
DCOM- 20221215
LR  - 20230328
IS  - 2047-2994 (Electronic)
IS  - 2047-2994 (Linking)
VI  - 11
IP  - 1
DP  - 2022 Dec 6
TI  - Infection prevention and control policies in hospitals and prevalence of highly 
      resistant microorganisms: an international comparative study.
PG  - 152
LID - 10.1186/s13756-022-01165-0 [doi]
LID - 152
AB  - BACKGROUND: There are differences in infection prevention and control (IPC) 
      policies to prevent transmission of highly resistant microorganisms (HRMO). The 
      aim of this study is to give an overview of the IPC policy of six European 
      hospitals and their HRMO prevalence, to compare the IPC policies of these 
      hospitals with international guidelines, and to investigate the hospitals' 
      adherence to their own IPC policy. METHODS: The participating hospitals were 
      located in Salzburg (Austria), Vienna (Austria), Kayseri (Turkey), Piraeus 
      (Greece), Rome (Italy) and Rotterdam (The Netherlands). Data were collected via 
      an online survey. Questions were aimed at prevalence rates in the years 2014, 
      2015, 2016 of carbapenemase-producing Klebsiella pneumoniae (CPK), 
      carbapenemase-producing Pseudomonas aeruginosa (CPPA), vancomycin-resistant 
      Enterococcus faecium (VRE) and hospitals' IPC policies of 2017. Implemented IPC 
      measures (i.e. with a self-reported adherence of > 90%) were counted (26 points 
      maximal). RESULTS: The self-reported prevalence of CPK per year was low in the 
      Austrian and Dutch hospitals and high in the Turkish and Greek hospitals. CPPA 
      was highly prevalent in the Turkish hospital only, while the prevalence of VRE in 
      four hospitals, except the Austrian hospitals which reported lower prevalence 
      numbers, was more evenly distributed. The Dutch hospital had implemented the most 
      IPC measures (n = 21), the Turkish and Greek hospitals the least (n = 14 and 7, 
      respectively). CONCLUSION: Hospitals with the highest self-reported prevalence of 
      CPK and CPPA reported the least implemented IPC measures. Also, hospitals with a 
      higher prevalence often reported a lower adherence to own IPC policy.
CI  - (c) 2022. The Author(s).
FAU - van Dijk, Manon D
AU  - van Dijk MD
AD  - Department of Medical Microbiology and Infectious Diseases, Erasmus MC University 
      Medical Centre Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
FAU - Voor In 't Holt, Anne F
AU  - Voor In 't Holt AF
AD  - Department of Medical Microbiology and Infectious Diseases, Erasmus MC University 
      Medical Centre Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
FAU - Alp, Emine
AU  - Alp E
AD  - Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, 
      Erciyes University, Kayseri, Turkey.
AD  - Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, 
      Ankara Yildirim Beyazit University, Ankara, Turkey.
FAU - Hell, Markus
AU  - Hell M
AD  - Department of Clinical Microbiology and Infection Control, MEDILAB-Academic 
      Teaching Laboratories, Paracelsus Medical University, Salzburg, Austria.
AD  - Teaching Hospital, Kardinal Schwarzenberg Klinikum, Paracelsus Medical 
      University, Schwarzach, Austria.
FAU - Petrosillo, Nicola
AU  - Petrosillo N
AD  - Clinical and Research Department for Infectious Diseases, National Institute for 
      Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
AD  - Department of Infection Control, University Hospital Campus Bio-Medico, Rome, 
      Italy.
FAU - Presterl, Elisabeth
AU  - Presterl E
AD  - Department of Infection Control and Hospital Epidemiology, Medical University of 
      Vienna, Vienna, Austria.
FAU - Tsakris, Athanasios
AU  - Tsakris A
AD  - Department of Microbiology, Medical School, University of Athens, Athens, Greece.
FAU - Severin, Juliette A
AU  - Severin JA
AD  - Department of Medical Microbiology and Infectious Diseases, Erasmus MC University 
      Medical Centre Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. 
      j.severin@erasmusmc.nl.
FAU - Vos, Margreet C
AU  - Vos MC
AD  - Department of Medical Microbiology and Infectious Diseases, Erasmus MC University 
      Medical Centre Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
CN  - ESCMID Study Group for Nosocomial Infections (ESGNI)
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221206
PL  - England
TA  - Antimicrob Resist Infect Control
JT  - Antimicrobial resistance and infection control
JID - 101585411
SB  - IM
EIN - Antimicrob Resist Infect Control. 2023 Mar 29;12(1):23. PMID: 36978143
MH  - Humans
MH  - *Policy
MH  - Austria
MH  - Greece
MH  - Italy
MH  - *Hospitals
PMC - PMC9727845
OTO - NOTNLM
OT  - Carbapenemase-producing Klebsiella pneumoniae
OT  - Carbapenemase-producing Pseudomonas aeruginosa
OT  - Drug Resistance
OT  - Hospitals
OT  - Infection control
OT  - Microbial
OT  - Policy
OT  - Prevalence
OT  - Surveys and Questionnaires
OT  - Vancomycin-resistant Enterococcus faecium
COIS- The authors declare that they have no competing interests.
EDAT- 2022/12/07 06:00
MHDA- 2022/12/15 06:00
PMCR- 2022/12/06
CRDT- 2022/12/06 23:55
PHST- 2022/05/06 00:00 [received]
PHST- 2022/10/08 00:00 [accepted]
PHST- 2022/09/20 00:00 [revised]
PHST- 2022/12/06 23:55 [entrez]
PHST- 2022/12/07 06:00 [pubmed]
PHST- 2022/12/15 06:00 [medline]
PHST- 2022/12/06 00:00 [pmc-release]
AID - 10.1186/s13756-022-01165-0 [pii]
AID - 1165 [pii]
AID - 10.1186/s13756-022-01165-0 [doi]
PST - epublish
SO  - Antimicrob Resist Infect Control. 2022 Dec 6;11(1):152. doi: 
      10.1186/s13756-022-01165-0.